1. The impact of osimertinib’ line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance;Fuchs;Lung Cancer,2021
2. TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs;Liao;Mol Ther Oncol,2024
3. Artificial intelligence-aided optical imaging for cancer theranostics;Xu;Semin Cancer Biol,2023
4. Biopsy-derived oral keratinocytes – a model to potentially test for oral mucosa radiation sensitivity;Thomsen;Clin Transl Radiat Oncol,2022
5. Circulating free DNA integrity index and promoter methylation of tumor suppressor gene P16, DAPK and RASSF1A as a biomarker for oropharyngeal squamous cell carcinoma;Kumari;Pathol Res Pract,2023